FDA OKs New Non-Statin, LDL-C Lowering Treatment
Esperion bempedoic acid (Nexletol) tablet has gained FDA approval for use in lowering low-density lipoprotein cholesterol (LDL-C) in adults with heterozygous familial hypercholesterolemia (HeFH) or…
Esperion bempedoic acid (Nexletol) tablet has gained FDA approval for use in lowering low-density lipoprotein cholesterol (LDL-C) in adults with heterozygous familial hypercholesterolemia (HeFH) or…
The U.S. Food and Drug Administration (FDA) has accepted the first generic of ProAir HFA (albuterol sulfate) Inhalation Aerosol for the therapy or blocking of…
A White House Council of Economic Advisers (CEA) report has been published this week. It discovered that medication costs fell by more than 11 percent…
The National Community Pharmacists Association is the advocate for community pharmacologists on the public policy issues that influence their sufferers and drugstores whether it’s at…
Now, the U.S. Food and Drug Administration took extra steps to secure a smooth regulatory change aimed at improving patient access to insulin results used…
While new data from the CDC suggests choosing for people between the ages of 13 and 64 years of age, only 40% have ever been…
Meeting for generic medications, low-profit boundaries, and low making facilities have all performed to remedy shortages in the United States. When modern generic drugs enter…
Although the currency of health system-based practice drugstores has grown regularly over the past decade, 2020 will mark a significant year. Payers, providers, and health…
The U.S. Food and Drug Administration now allowed three drugs for nonprescription, or over-the-counter (OTC), use through a process described a prescription (Rx)-to-OTC switch. The…
CVS Health’s fourth-quarter 2019 results brought enhanced profit and earnings per share. The Woonsocket, R.I.-based company saw fourth-quarter earnings of $66.9 billion and $1.73 in…